Efficacy and safety of
            LY2963016
            insulin glargine compared with insulin glargine (
            L
            antus®) in patients with type 1 diabetes in a randomized controlled trial: the
            ELEMENT
            1 study

T. C. Blevins; D. Dahl; J. Rosenstock; L. L. Ilag; W. J. Huster; J. S. Zielonka; R. K. Pollom; M. J. Prince

doi:10.1111/dom.12496

Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine ( L antus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12496 ◽

2015 ◽

Vol 17 (8) ◽

pp. 726-733 ◽

Cited By ~ 44

Author(s):

T. C. Blevins ◽

D. Dahl ◽

J. Rosenstock ◽

L. L. Ilag ◽

W. J. Huster ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring

Diabetes Obesity and Metabolism ◽

10.1111/dom.13751 ◽

2019 ◽

Vol 21 (8) ◽

pp. 1906-1913 ◽

Cited By ~ 3

Author(s):

Jeremy Pettus ◽

Jasvinder Gill ◽

Sachin Paranjape ◽

John Stewart ◽

Shilpy Malla ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Controlled Trial ◽

Glucose Monitoring ◽

Adult Patients ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1926 ◽

2020 ◽

Vol 43 (7) ◽

pp. 1512-1519 ◽

Cited By ~ 3

Author(s):

Thomas Danne ◽

William V. Tamborlane ◽

Oleg A. Malievsky ◽

Denise R. Franco ◽

Tomoyuki Kawamura ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Children And Adolescents ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: a phase III , randomized, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14463 ◽

2021 ◽

Author(s):

Xiang Yan ◽

Shan Jiang ◽

Ying Lou ◽

Zhiguang Zhou

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Chinese Patients ◽

Comparable Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes

PEDIATRICS ◽

10.1542/peds.2007-1679 ◽

2008 ◽

Vol 121 (3) ◽

pp. e466-e472 ◽

Cited By ~ 23

Author(s):

K. Hassan ◽

L. M. Rodriguez ◽

S. E. Johnson ◽

S. Tadlock ◽

R. A. Heptulla

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Newly Diagnosed ◽

Insulin Analogs ◽

Randomized Controlled ◽

Acting Insulin ◽

Neutral Protamine Hagedorn

Download Full-text

Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14060 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1516-1526 ◽

Cited By ~ 6

Author(s):

Chantal Mathieu ◽

Gottfried Rudofsky ◽

Moshe Phillip ◽

Eiichi Araki ◽

Marcus Lind ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Term Efficacy

Download Full-text

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

Diabetes Care ◽

10.2337/dc11-2264 ◽

2012 ◽

Vol 35 (10) ◽

pp. 2012-2017 ◽

Cited By ~ 122

Author(s):

E. R. Mathiesen ◽

M. Hod ◽

M. Ivanisevic ◽

S. Duran Garcia ◽

L. Brondsted ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Pregnant Women ◽

Insulin Detemir ◽

Controlled Trial ◽

Efficacy And Safety ◽

Nph Insulin ◽

Randomized Controlled ◽

Safety Outcomes

Download Full-text

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Diabetes Care ◽

10.2337/dc10-1925 ◽

2011 ◽

Vol 34 (3) ◽

pp. 661-665 ◽

Cited By ~ 121

Author(s):

K. I. Birkeland ◽

P. D. Home ◽

U. Wendisch ◽

R. E. Ratner ◽

T. Johansen ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Insulin Degludec ◽

Randomized Controlled ◽

Acting Insulin ◽

Long Acting ◽

New Generation

Download Full-text

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12619 ◽

2016 ◽

Vol 18 (4) ◽

pp. 375-383 ◽

Cited By ~ 52

Author(s):

M. Matsuhisa ◽

M. Koyama ◽

X. Cheng ◽

Y. Takahashi ◽

M. C. Riddle ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Controlled Trial ◽

Randomized Controlled ◽

Japanese Adults ◽

Mealtime Insulin

Download Full-text

Two-Year Efficacy and Safety of AIR Inhaled Insulin in Patients with Type 1 Diabetes: An Open-Label Randomized Controlled Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2009.0040 ◽

2009 ◽

Vol 11 (s2) ◽

pp. S-5-S-16 ◽

Cited By ~ 11

Author(s):

Satish K. Garg ◽

Chantal Mathieu ◽

Nadeem Rais ◽

Haitao Gao ◽

Janet A. Tobian ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Open Label ◽

Inhaled Insulin ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc18-0623 ◽

2018 ◽

Vol 41 (9) ◽

pp. 1938-1946 ◽

Cited By ~ 100

Author(s):

Chantal Mathieu ◽

Paresh Dandona ◽

Pieter Gillard ◽

Peter Senior ◽

Christoph Hasslacher ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text